Long-term therapy with organic nitrates: The pros and cons of nitric oxide replacement therapy

Journal of the American College of Cardiology

Volumn 44, Issue 3, 2004, Pages 632-634

  Gori, Tommaso ^a   Parker, John D ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOSORBIDE MONONITRATE; NICORANDIL; NIFEDIPINE; NITRIC OXIDE; ORGANIC NITRATE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; LONG TERM CARE; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 4043082804     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.05.031     Document Type: Editorial

References (21)

1. Ignarro L.J., Lippton H., Edwards J.C., et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 218:1981;739-749
2. Chen Z., Zhang J., Stamler J.S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA. 99:2002;8306-8311
3. Kojda G., Patzner M., Hacker A., Noack E. Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate A novel mechanism to explain preferential venodilation of organic nitrates. Mol Pharmacol. 53:1998;547-554
4. + channels on nitroglycerin-mediated vasorelaxation in humans. Eur J Pharmacol. 446:2002;145-150
5. Kleschyov A.L., Oelze M., Daiber A., et al. Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res. 93:2003;e104-e112
6. Schulz E., Tsilimingas N., Rinze R., et al. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation. 105:2002;1170-1175
7. Gori T., Mak S.S., Kelly S., Parker J.D. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol. 38:2001;1096-1101
8. Fung H.L. Biochemical mechanism of nitroglycerin action and tolerance Is this old mystery solved? Annu Rev Pharmacol Toxicol. 44:2004;67-85
9. Gori T., Parker J.D. Nitrate tolerance A unifying hypothesis. Circulation. 106:2002;2510-2513
10. Gewaltig M.T., Kojda G. Vasoprotection by nitric oxide Mechanisms and therapeutic potential. Cardiovasc Res. 55:2002;250-260
11. Munzel T., Sayegh H., Freeman B.A., Tarpey M.M., Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 95:1995;187-194
12. Müller S, König I, Meyer W, Kojda G. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol 2004;44:624-31.
13. Parker J.D. Potential problems with intermittent nitrate therapy. Can J Cardiol. 12:(Suppl C):1996;22C-24C
14. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 1994;343:1115-22.
15. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4 A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-685
16. Fox K.M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 362:2003;782-788
17. Lubsen J., Poole-Wilson P.A., Pocock S.J., et al. Design and current status of ACTION A coronary disease trial investigating outcome with nifedipine GITS. gastro-intestinal therapeutic system. Eur Heart J. 19:(Suppl I):1998;I20-I32
18. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359:1269-75.
19. Gori T., Al Hesayen A., Jolliffe C., Parker J.D. Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers. Am J Cardiol. 91:2003;1392-1394
20. Gori T., Floras J.S., Parker J.D. Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans. J Am Coll Cardiol. 40:2002;2000-2005
21. Parker J.D., Parker J.O. Nitrate therapy for stable angina pectoris. N Engl J Med. 338:1998;520-531